Sanofi To Pay Regeneron Up To $8B In Immunology Alliance
French multinational pharmaceutical and healthcare company Sanofi said Thursday it will pay Regeneron Pharmaceuticals as much as $8 billion under a deal to expand their partnership as they look to fast-track...To view the full article, register now.
Already a subscriber? Click here to view full article